These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3252890)

  • 21. Treatment of agitation using Depakote: a patient with dementia.
    Vance H; Kauffman C; Miller B; Mansour T
    Psychiatry; 2003; 66(4):358-9. PubMed ID: 14964697
    [No Abstract]   [Full Text] [Related]  

  • 22. [Agitation and aggressive behavior in demented patients: pain therapy improves behavioral problems].
    MMW Fortschr Med; 2012 Jan; 154(1):76-7. PubMed ID: 22642013
    [No Abstract]   [Full Text] [Related]  

  • 23. Sleep and agitation in nursing home residents with and without dementia.
    Brown DT; Westbury JL; Schüz B
    Int Psychogeriatr; 2015 Dec; 27(12):1945-55. PubMed ID: 26424155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic use of carbamazepine for treatment of agitation and affective disorders in geriatric psychiatry patients].
    Lemke MR; Stuhlmann W
    Psychiatr Prax; 1994 Jul; 21(4):147-50. PubMed ID: 7938323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The response of agitated behavior to pain management in persons with dementia.
    Husebo BS; Ballard C; Cohen-Mansfield J; Seifert R; Aarsland D
    Am J Geriatr Psychiatry; 2014 Jul; 22(7):708-17. PubMed ID: 23611363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbamazepine treatment of agitation associated with dementia.
    Leibovici A; Tariot PN
    J Geriatr Psychiatry Neurol; 1988; 1(2):110-2. PubMed ID: 3252879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic treatment of agitation associated with dementia.
    Risse SC; Barnes R
    J Am Geriatr Soc; 1986 May; 34(5):368-76. PubMed ID: 2870097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Withdrawal from controlled carbamazepine therapy followed by further carbamazepine treatment in patients with dementia.
    Tariot PN; Jakimovich LJ; Erb R; Cox C; Lanning B; Irvine C; Podgorski CA
    J Clin Psychiatry; 1999 Oct; 60(10):684-9. PubMed ID: 10549685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoxetine in the treatment of agitated dementia.
    Sobin P; Schneider L; McDermott H
    Am J Psychiatry; 1989 Dec; 146(12):1636. PubMed ID: 2589559
    [No Abstract]   [Full Text] [Related]  

  • 31. Behavioral and psychological symptoms in patients with dementia as a target for pharmacotherapy with risperidone.
    Rabinowitz J; Katz IR; De Deyn PP; Brodaty H; Greenspan A; Davidson M
    J Clin Psychiatry; 2004 Oct; 65(10):1329-34. PubMed ID: 15491235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A structured trial of risperidone for the treatment of agitation in dementia.
    Lavretsky H; Sultzer D
    Am J Geriatr Psychiatry; 1998; 6(2):127-35. PubMed ID: 9581208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial.
    Fossey J; Ballard C; Juszczak E; James I; Alder N; Jacoby R; Howard R
    BMJ; 2006 Apr; 332(7544):756-61. PubMed ID: 16543297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agitation in nursing home residents with dementia (VIDEANT trial): effects of a cluster-randomized, controlled, guideline implementation trial.
    Rapp MA; Mell T; Majic T; Treusch Y; Nordheim J; Niemann-Mirmehdi M; Gutzmann H; Heinz A
    J Am Med Dir Assoc; 2013 Sep; 14(9):690-5. PubMed ID: 23827658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biography and dementia. Origin of challenging behavior in patients with multi-infarct dementia or senile dementia of the Alzheimer type in long term care with reference the biographical level].
    Höwler E
    Pflege Z; 2011 Oct; 64(10):612-5. PubMed ID: 22032036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shifting from haloperidol to risperidone for behavioral disturbances in dementia: safety, response predictors, and mood effects.
    Lane HY; Chang YC; Su MH; Chiu CC; Huang MC; Chang WH
    J Clin Psychopharmacol; 2002 Feb; 22(1):4-10. PubMed ID: 11799336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
    Daiello LA
    Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olanzapine versus haloperidol in the treatment of agitation in elderly patients with dementia: results of a randomized controlled double-blind trial.
    Verhey FR; Verkaaik M; Lousberg R;
    Dement Geriatr Cogn Disord; 2006; 21(1):1-8. PubMed ID: 16244481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral midazolam for dementia-related response agitation.
    Passmore MJ; Sheldon L; Lax S; Wilkins-Ho M; Illing M
    J Am Geriatr Soc; 2009 Mar; 57(3):561-2. PubMed ID: 19278400
    [No Abstract]   [Full Text] [Related]  

  • 40. Valproate in the treatment of behavioral agitation in elderly patients with dementia.
    Lott AD; McElroy SL; Keys MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):314-9. PubMed ID: 7580190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.